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SALM1 (SALM (synaptic adhesion-likemolecule), also known as LRFN2 (leucine rich repeat and fibronectin type III domain containing), is a
postsynaptic density (PSD)-95-interacting synaptic adhesion molecule implicated in the regulation of NMDA receptor (NMDAR) clustering
largely based on in vitrodata, although its in vivo functions remain unclear.Here, we found thatmice lacking SALM1/LRFN2 (Lrfn2 /mice)
showanormal density of excitatory synapses but altered excitatory synaptic function, including enhancedNMDAR-dependent synaptic trans-
missionbut suppressedNMDAR-dependent synaptic plasticity in thehippocampalCA1 region.Unexpectedly, SALM1expressionwasdetected
in both glutamatergic and GABAergic neurons and Lrfn2 / CA1 pyramidal neurons showed decreases in the density of inhibitory synapses
and the frequency of spontaneous inhibitory synaptic transmission. Behaviorally, ultrasonic vocalization was suppressed in Lrfn2 / pups
separated fromtheirmothers andacoustic startlewas enhanced, but locomotion, anxiety-likebehavior, social interaction, repetitivebehaviors,
and learning and memory were largely normal in adult male Lrfn2 /mice. These results suggest that SALM1/LRFN2 regulates excitatory
synapse function, inhibitory synapse development, and social communication and startle behaviors inmice.
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Introduction
Synaptic adhesion molecules, with the prototypical molecules
being neuroligins and neurexins, have been shown to regulate the
development, function, and plasticity of neuronal synapses
(Dalva et al., 2007; Biederer and Stagi, 2008; Shen and Scheiffele,
2010; Siddiqui andCraig, 2011; Krueger et al., 2012;Missler et al.,
2012; Valnegri et al., 2012; Takahashi and Craig, 2013; Um and
Ko, 2013; Bemben et al., 2015; Ko et al., 2015; deWit and Ghosh,
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Significance Statement
Synaptic adhesionmolecules regulate synapse development and function, which govern neural circuit and brain functions. The SALM/
LRFN (synaptic adhesion-like molecule/leucine rich repeat and fibronectin type III domain containing) family of synaptic adhesion
proteins consists of five known members for which the in vivo functions are largely unknown. Here, we characterized mice lacking
SALM1/LRFN2 (SALM1KO) known to associatewithNMDA receptors (NMDARs) and found that thesemice showed alteredNMDAR-
dependent synaptic transmission and plasticity, as expected, but unexpectedly also exhibited suppressed inhibitory synapse develop-
ment and synaptic transmission. Behaviorally, SALM1KOpups showed suppressed ultrasonic vocalization upon separation from their
mothersandSALM1KOadults showedenhancedresponses to loudacoustic stimuli.These results suggest thatSALM1/LRFN2regulates
excitatory synapse function, inhibitory synapse development, social communication, and acoustic startle behavior.
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2016; Jang et al., 2017; Su¨dhof, 2017; Um and Ko, 2017; Yuzaki,
2017). Among such synaptic adhesion molecules is the leucine-
rich repeat (LRR)-containing SALM/LRFN (synaptic adhesion-
likemolecule/leucine rich repeat and fibronectin type III domain
containing) family comprising five known members: SALM1/
LRFN2, SALM2/LRFN1, SALM3/LRFN4, SALM4/LRFN3, and
SALM5/LRFN5 (Ko et al., 2006; Morimura et al., 2006; Wang et
al., 2006; Nam et al., 2011; Lie et al., 2018).
SALM family proteins share a similar domain structure con-
sisting of six LRRs, an Ig domain, and a fibronectin type III
domain in the extracellular region, followed by a single trans-
membrane domain and a cytoplasmic region. The extreme
C-terminal tails of SALM1-3, but not SALM4/5, contain a PDZ
domain-binding motif that interacts with the PDZ domains of
PSD-95, an abundant postsynaptic scaffolding protein (Sheng
and Kim, 2011; Won et al., 2017). The cytoplasmic regions of
individual SALMs share minimal amino acid sequence identities,
except for the C-terminal PDZ-binding motif, suggestive of func-
tional diversity. However, SALMs associate with each other to form
various homomeric and heteromeric complexes in vivo (Seabold et
al., 2008; Lie et al., 2016), perhaps for concerted actions.
Functionally, SALMs regulate synapse development. SALM3
and SALM5, but not other SALMs, promote synapse develop-
ment by interacting with presynaptic LAR family receptor pro-
tein tyrosine phosphatases (Mah et al., 2010; Li et al., 2015; Choi
et al., 2016). Mice lacking SALM3/LRFN4 display suppressed ex-
citatory synapse development (Li et al., 2015). SALM4/LRFN3,
despite lacking synaptogenic activity, interacts in ciswith SALM3
and inhibits SALM3-dependent synapse development (Lie et al.,
2016).
SALMs also regulate excitatory synaptic transmission and
plasticity. SALM1 associates with NMDA receptors (NMDARs)
and induces their dendritic clustering through a mechanism that
requires its C-terminal PDZ-binding motif in vitro (Wang et al.,
2006), but it does not interact with AMPA receptors (AMPARs).
SALM2 promotes excitatory synapse maturation by associating
with both NMDARs and AMPARs (Ko et al., 2006). Mice lacking
SALM1/LRFN2 have recently been reported to display impair-
ments in excitatory synapse maturation and enhancements in
long-term potentiation (LTP) that are associated with autistic-
like social deficits and stereotypies as well as enhanced learning
and memory (Morimura et al., 2017).
SALMs have also been implicated in human brain disorders.
SALM1/LRFN2 has been associated with autism spectrum disor-
ders (ASD; Voineagu et al., 2011; Morimura et al., 2017), schizo-
phrenia (Morimura et al., 2017), working memory deficits
(Thevenon et al., 2016), and antisocial personality disorders
(Rautiainen et al., 2016). However, how a SALM1/LRFN2 defi-
ciency in humans leads to these abnormalities remains unclear.
In the present study, we further explored the in vivo functions
of SALM1using an independentLrfn2-KOmouse line (Lrfn2 /
mice) and found that SALM1 is important for excitatory synaptic
plasticity, inhibitory synapse development, and ultrasonic vocal-
ization (USV) and acoustic startle.
Materials andMethods
cDNA constructs. Full-length human SALM1 (aa 1–788) in pcDNA3.1
Myc HisA vector has been described previously (Mah et al., 2010).
Antibodies. SALM1 (2022) guinea pig polyclonal antibodies were gen-
erated using the last 30 aa of mouse SALM1 as immunogen (NGMLLP-
FEESDLVGARGTFGSSEWVMESTV). The following antibodies have
been described previously: GluA1 (#1193; Kim et al., 2009), GluA2
(#1195; Kim et al., 2009), Homer1 (#1133; Sala et al., 2001), PSD-93
(#1634; Kim et al., 2009), PSD-95 (#1688; Yang et al., 2011), SALM2
(#2058; Li et al., 2015), SALM3 (#2024; Lie et al., 2016), SALM4 (#2026;
Li et al., 2015), and SALM5 (#1911; Mah et al., 2010). The following an-
tibodies were purchased: GAD65 (Abcam ab85866, RRID:AB_1860505),
GluN1 (Transduction Laboratories 556308, RRID:AB_2314954),
GluN2A (Alomone Labs AGC-002, RRID:AB_2040025), GluN2B (Alo-
mone Labs AGC-003, RRID:AB_2040028), mGluR5 (Millipore AB5675,
RRID:AB_2295173), synapsin I (Millipore AB1543, RRID:AB_2200400), syn-
aptophysin (Santa Cruz Biotechnology sc-9116, RRID:AB_2199007), VGluT1
(Synaptic Systems 135 303, RRID:AB_887875), VGAT (Synaptic Systems 131
003, RRID:AB_887869), gephyrin (Synaptic Systems 147 111, RRID:
AB_887719),-tubulin (Sigma-Aldrich T5168, RRID:AB_477579), andNeuN
(MilliporeMAB377, RRID:AB_2298772).
Crude synaptosomes. Crude synaptosomes from theWTand Lrfn2 /
hippocampus [postnatal day 20 (P20)–P23; males and females] were
prepared as described previously (Huttner et al., 1983). Briefly, hip-
pocampal homogenates were centrifuged at 1000 g to remove nuclear
and other debris, followed by resuspension and centrifugation of the
pellet at 10,000 g to obtain the P2 (crude synaptosomal) fraction.
Generation and characterization of Lrfn2/ mice. Lrfn2-deficient
mice were generated by Biocytogen by targeting the exon 2 of the Lrfn2
gene under the genetic background of C57BL/6J. To remove the EGFP
Neo cassette, mice were crossed with Protamine-Flp mice. For global
Lrfn2 KO in the whole body, mice removed of the EGFP Neo cassette
were crossed with Protamine-Cre mice. The resulting mice were crossed
with WT mice to produce heterozygous mice (Lrfn2/). Male and
female Lrfn2/mice were crossed to produce WT and Lrfn2 /mice
for all the experiments performed except for X-gal experiments. Mice were
PCR-genotyped using the following primers: for WT allele: 5-ATG-
GAGACTCTGCTTGGTGGGC-3 (forward) and 5-GTTAGCAAG
GAAGCCTGGGAGC-3 (reverse); for KO allele: 5-CCAAGTAACTAG-
GTTGTTCTGGGC-3 and 5-TGAGGAATCTGGAACCGACCAG-3.
Theprimers forRT-PCRwere5-AATAAGCTGCTCAGGGCTCTC-3and
5-CAGACAGATTCTGGCAGACG-3. For X-gal staining, mouse sperm
carrying the LacZ cassette in the Lrfn2 gene in the genetic background of
C57BL/6NTacwaspurchased fromKOMP(VG15208)andused toproduce
progenies for X-gal staining using in vitro fertilization with oocytes in the
C57BL/6J Tac background. Heterozygous male mice were used for X-gal
staining.
X-gal staining. Mice (P49) were perfused transcardially with heparinized
1 PBS and 4% paraformaldehyde. Vibratome brain sections (250 m
thickness) were incubated in staining solution containing 5mMK3Fe(CN)6,
5mMK4Fe(CN)6●3H2O, 2mMMgCl2, 0.01%deoxycholate,1mg/ml X-gal,
and 0.02%NP-40 in PBS for 3 h at room temperature.
Electron microscopy. WT and Lrfn2 /mice were deeply anesthetized
with sodium pentobarbital (80 mg/kg, intraperitoneal) and intracardi-
ally perfused with 10 ml of heparinized normal saline, followed by 50 ml
of a freshly prepared fixative of 2.5% glutaraldehyde and 1%paraformal-
dehyde in 0.1 M phosphate buffer (PB, pH 7.4). Hippocampus was re-
moved from the whole brain, postfixed in the same fixative for 2 h, and
stored in PB overnight at 4°C. Sections were cut transversely on a Vi-
bratome at 70 m. The sections were osmicated with 0.5% osmium
tetroxide (in PB) for 1 h, dehydrated in graded alcohols, flat embedded in
Durcupan ACM (Fluka), and cured for 48 h at 60°C. Small pieces con-
taining stratum radiatumof hippocampal CA1 regionwere cut out of the
wafers and glued onto the plastic block by cyanoacrylate. Ultrathin sec-
tions were cut and mounted on Formvar-coated single slot grids. For
quantification of excitatory synapses, sections were stained with uranyl
acetate and lead citrate and examined with an electron microscope
(Montclair Microscopy and Microanalysis Research Laboratory, RRID:
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SCR_012453) at 80 kV accelerating voltage. For quantification of inhib-
itory synapse, sections were further immunogold stained for GABA.
Postembedding immunogold staining for GABA. Sections were immu-
nostained for GABA by postembedding immunogold method, as de-
scribed previously (Paik et al., 2007) with some modifications. In brief,
the grids were treated for 5 min in 1% periodic acid to etch the resin and
for 8 min in 9% sodium periodate to remove the osmium tetroxide, and
then washed in distilled water, transferred to Tris-buffered saline con-
taining 0.1% Triton X-100 (TBST; pH 7.4) for 10 min, and incubated in
2% human serum albumin (HSA) in TBST for 10 min. The grids were
then incubated with rabbit antiserum against GABA (GABA 990,
1:10,000) in TBST containing 2%HSA for 2 h at room temperature. The
antiserum (a kind gift from professor O.P. Ottersen at the Center for
Molecular Biology and Neuroscience, University of Oslo) was raised
against GABA conjugated to bovine serum albumin with glutaraldehyde
and formaldehyde (Kolston et al., 1992) and characterized by spot testing
(Ottersen and Storm-Mathisen, 1984). To eliminate cross-reactivity, the
diluted antiserum was preadsorbed overnight with glutaraldehyde (G)-
conjugated glutamate (500 M, prepared according as described previ-
ously; Ottersen et al., 1986). After extensive rinsing in TBST, grids were
incubated for 3 h in goat anti-rabbit IgG coupled to 15 nm gold particles
(1:25 in TBST containing 0.05% polyethylene glycol; BioCell). After a rinse
in distilled water, the grids were counterstainedwith uranyl acetate and lead
citrate and examined with an electron microscope (Montclair Microscopy
andMicroanalysisResearchLaboratory,RRID:SCR_012453) at 80kVaccel-
erating voltage. To assess the immunoreactivity for GABA, gold particle
density (number of gold particles per square millimeter) of each GABA-
immunopositive () terminal was compared with gold particle density of
terminals that containg round vesicles and make asymmetric synaptic con-
tact with dendritic spines (background density). Terminals were considered
GABA if the gold particle density over the vesicle-containing areas was at
least five times higher than background density.
Quantitative analysis of excitatory and inhibitory synapses. For quanti-
fication of excitatory synapses, 24 electron micrographs representing
368.9m2 neuropil regions in eachmouse were taken at a 40,000. The
number of spines (PSD density), proportion of perforated spines, PSD
length, and PSD thickness from each of three WT and Lrfn2 / mice
were quantified with ImageJ (RRID:SCR_003070). For quantification of
inhibitory synapses, 24 electron micrographs representing 655.5 m2
neuropil regions in each mouse were taken at 30,000. Number of
GABA terminals showing clear PSD (inhibitory synapse density),
length and thickness of PSD contacting GABA terminals from each of
three WT and Lrfn2 / mice were quantified with ImageJ (RRID:
SCR_003070). The measurements were all performed by an experi-
menter blinded to the genotype. Digital images were captured with
Digital Micrograph software driving a CCD camera (SC1000 Orius; Ga-
tan) and saved as TIFF files. Brightness and contrast of the images were
adjusted using Adobe Photoshop 7.0 (RRID:SCR_014199).
In situ hybridization. Mouse brains at various developmental stages
[embryonic day 18 (E18) and P0, P7, P14, P21, and P42] were extracted
and rapidly frozen in isopentane prechilled with dry ice. Brain sections
were prepared with a cryostat and thaw-mounted onto gelatin-coated
slides and fixed in 4% paraformaldehyde. Two independent hybridiza-
tion probes targeted approximately the N- and C-terminal regions of the
Lrfn2 gene (NM_027452.3). For probe 1, the forward sequence was
TACGCCGGATCCGTGGGCTGCTGGCTTTT and reverse sequence
was TACGCCGAATTCTGGCTGATGGTGTTCCTG. For probe 2, the
forward sequence was TACGCCGGATCCTGCTCTTGCCCTTTGAGG
and the reverse sequence was TACGCCGAATTCATGGGGAAGGG-
GGTGTAG.
FISH. In brief, frozen sections (14 m thick) were cut coronally
through the hippocampal formation. Sections were thaw-mounted onto
Superfrost Plus Microscope Slides (Fisher Scientific, 12-550-15). The
sections were fixed in 4% formaldehyde for 10 min, dehydrated in in-
creasing concentrations of ethanol for 5 min, and air-dried. Tissues were
then pretreated for protease digestion for 10 min at room temperature.
For RNA detection, incubations with different amplifier solutions were
performed in a HybEZ hybridization oven (Advanced Cell Diagnostics)
at 40°C. In this study, we used fluorescent probes to label Lrfn2, Gad1/2,
and Vglut1/2; mixtures of Gad1  Gad2 probes and Vglut1  Vglut2
probes were used to collectively label GABAergic and glutamatergic neu-
rons, respectively. Synthetic oligonucleotides in the probes were comple-
mentary to the following nucleotide regions in the target genes; Lrfn2,
nucleotide sequence 542–2041 of Mm-Lrfn2-C1; Vglut1, 464-415 of
Mm-Slc17a7-C2, Vglut2, 1986–2998 ofMm-Slc17a6-C2, Gad1, 62-3113
of Mm-Gad1-C3, Gad2, 552–1506 of Mm-Gad2-C3 (Advanced Cell Di-
agnostics), respectively. The labeled probes were conjugated to Atto 550
(C1), Atto 647 (C2), andAlexa Fluor 488 (C3). The sections were hybrid-
ized at 40°C with labeled probe mixtures (C1  C2  C3) per slide for
2 h. Then the nonspecifically hybridized probes were removed by wash-
ing the sections 3 times each in 1 wash buffer at room temperature for
2 min. Amplification steps involved sequential incubations with Ampli-
fier 1-FL for 30 min, Amplifier 2-FL for 15 min, Amplifier 3-FL for 30
min, and Amplifier 4 Alt B-FL at 40°C for 15 min. Each amplifier solu-
tions were removed by washing 3 times with 1wash buffer for 2 min at
RT. Fluorescent images were acquired using an LSM 700 microscope
(Zeiss) and analyzed using ImageJ (RRID:SCR_003070).
Electrophysiology. For whole-cell patch-clamp analysis, sagittal hip-
pocampal and coronal mPFC slices (300m thick) from Lrfn2 /mice
and theirWT littermates at P21–P24 were prepared using a vibratome in
ice-cold section buffer containing the following (in mM): 212 sucrose, 25
NaHCO3, 5 KCl, 1.25 NaH2PO4, 0.5 CaCl2, 3.5MgSO4, 10 D-glucose, 1.2
L-ascorbic acid, and 2 Na-pyruvate bubbled with 95% O2/5% CO2. The
slices were recovered at 32°C for 30 min in normal artificial CSF (ACSF)
containing the following (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25
NaHCO3, 10 glucose, 2.5 CaCl2, and 1.3 MgCl2 oxygenated with 95%
O2/5% CO2. Stimulation and recording pipettes were pulled from boro-
silicate glass capillaries (Harvard Apparatus) using a micropipette elec-
trode puller (Narishege). Whole-cell patch-clamp recordings were made
using a MultiClamp 700B amplifier (Molecular Devices) and Digidata
1440A (Molecular Devices) under visual control with differential inter-
ference contrast illumination in an upright microscope. Signals were
filtered at 2 kHz and digitized at 10 kHz. Miniature excitatory postsyn-
aptic currents (mEPSCs)were obtained at a holding potential of70mV
using patch electrode (3–4M) filled with an internal solution contain-
ing the following (inmM): 100 CsMeSO4, 10 TEA-Cl, 8 NaCl, 10 HEPES,
5 QX-314-Cl, 2 Mg-ATP, 0.3 Na-GTP, and 10 EGTA, pH 7.25, 295
mOsm. TTX (0.5 M) and picrotoxin (100 M) were added to ACSF to
inhibit spontaneous action potential-mediated synaptic currents and IP-
SCs, respectively. For spontaneous EPSCs (sEPSCs), the same experi-
mental conditions used for mEPSC measurements were used, except for
omitting TTX. To measure miniature inhibitory postsynaptic currents
(mIPSCs), cells were also held at70 mV and the pipette internal solu-
tion contained the following (in mM): 115 CsCl, 10 TEA-Cl, 8 NaCl, 10
HEPES, 5 QX-314-Cl, 4 Mg-ATP, 0.3 Na-GTP, and 10 EGTA, pH 7.35,
295 mOsm. To inhibit excitatory synaptic currents, TTX (0.5 M),
D-AP5 (25 M), and NBQX (10 M) were added to the ACSF. sIPSC
measurements were made in the absence of TTX.
For measurements of the NMDA/AMPA ratio, sagittal hippocampal
slices (300 m thick) were prepared. The recording pipettes (3–4 M)
were filled with the same internal solution used for mEPSC measure-
ments. Picrotoxin (100 M) was added to the ACSF. CA1 pyramidal
neurons were voltage clamped at 70 mV and EPSCs were evoked at
every 15 s. AMPAR-mediated EPSCs were recorded at 70 mV and 20
consecutive responses were recorded after stable baseline. After record-
ingAMPAR-mediated EPSCs, holding potential was changed to40mV
to record NMDAR-mediated EPSCs. The NMDA component was mea-
sured at 60 ms after the stimulation. The NMDA/AMPA ratio was calcu-
lated by dividing the mean value of 20 NMDA-EPSC peak amplitudes by
the mean value of 20 AMPA-EPSC peak amplitudes. Data were acquired
using Clampex 10.4 (Molecular Devices) and analyzed using Clampfit
10.4 (NMDA/AMPA ratio; Molecular Devices).
To measure input/output responses of NMDA-EPSCs, synaptic cur-
rents were recorded at 40 mV with a pipette solution containing the
following (in mM): 100 Cs-gluconate, 10 TEA-Cl, 10 CsCl, 8 NaCl, 10
NaCl, 10 EGTA, 4 Mg-ATP, 0.3 Na-GTP, 0.5 and QX-314-Cl, pH 7.36.
The GABAAR antagonist picrotoxin (100 M) and the AMPAR antago-
nist NBQX (10 M) were added to the ACSF. The stimulating electrode
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was placed in the stratum radiatum 100–120 m from the neuron
under recording and synaptic responses were evoked by a series (20 s
interval) of pulses with different stimulation intensities (0.5–4 V). To
avoid potential confounding effects of propagated spike activity, the ini-
tial slopes rather than peak amplitudes of NMDA-EPSCs were analyzed
offline (Kim et al., 2009). The data were discarded when the series resis-
tance changed by10% during the recordings.
For field recordings, sagittal hippocampal slices (400 m) were pre-
pared. The pipettes were filled with ACSF. For input/output and paired-
pulse ratio experiments, CA1 field EPSP (fEPSP) was evoked every 20 s
and the stable baseline was recorded for 10 min. For input/output re-
cording, gradually increasing stimuliwere delivered to induce fiber volley
amplitudes of 0.05–0.3 mV/ms. For paired-pulse ratio recording, inter-
stimulus intervals were 25, 50, 100, 200, and 300 ms. For long term
potentiation (LTP) measurements, the Schaffer collateral pathway was
stimulated every 20 s and a stable baseline was maintained for 20 min.
LTP stimuli were high-frequency stimulation (HFS; 100Hz, 1 s) or theta-
burst stimulation (TBS; 10 trains of 4 pulses at 100 Hz, delivered at 5 Hz,
repeated 4 times at 10 s interval). For long term depression (LTD) exper-
iments, picrotoxin (100 M) were added to ACS, and low-frequency
stimulation (LFS; 1 Hz, 900 pulses) was given. After LTP or LTD stimu-
lus, the responses were recorded for 1 h.
Animal behavioral tests. Male mice at2–6 months of age were used
for all behavioral tests except the pup retrieval test. All mice were fed ad
libitum, housed under a 12/12 h light/dark cycle, and all mouse behaviors
were performed usingmice at their light-off/dark periods. All procedures
were approved by the Committee of Animal Research at KAIST
(KA2012-19). Animal used in behavioral tests were generated from
crossingmale and female heterozygousmice. All tests used littermates or
age-matched mice.
Open-field test. Mice were placed into a white 40 40 40 cm open-
field box and allowed to explore freely for 1 h under complete darkness
(0 lux) or 110 lux. Mice movements were recorded using a video cam-
era (infrared camera in the case of complete darkness) and analyzed
using EthoVision XT 10 software (Noldus, RRID:SCR_000441).
LABORAS monitoring of movements. Home cage locomotion behav-
iors of mice were recorded and analyzed using Laboratory Animal Be-
havior Observation Registration and Analysis System (LABORAS;
Metris) for 72 consecutive hours.
Elevated plus-maze. The maze consisted of two open arms, two closed
arms, and a center zone elevated to a height 50 cm above the floor. Mice
were initially placed on the center zone faced to the open armand allowed
to explore the space freely for 8 min. Light condition was80 lux.
Light–dark test. The apparatus had a dimension of 12 30 20 cm for
the light chamber (600 lux) and 14 13 20 cm for the dark chamber
(5 lux).Micewere placed in the center of the light chamber and allowed
to explore the whole apparatus freely for 10 min. Time spent in the light
chamber was analyzed using EthoVision XT 10 software.
Three-chamber test. Subjectmicewere isolated for 3d in their homecages
before the experiment. The apparatus consisted of three-chamber and both
sidechambershadasteelwirecage in thecorner toplace inanimateobjectsor
mice. First, mice were put in the center zone and allowed to explore the
whole apparatus freely for 10min.Next, a strangermouse (S1)was placed in
a wire cage in a side chamber and an inanimate object (O) was placed in
another wire cage.Mice were then allowed to explore freely for 10min. The
strangermousewas randomly positioned in the left or right chamber. Then,
the object was replaced with a novel stranger mouse (S2) and mice were
allowed to explore the apparatus freely for 10min.Time spent in each cham-
ber and time spent sniffing the wire cage containing O, S1, or S2 were ana-
lyzed using EthoVision XT 10 software.
Direct interaction test. Subject mice were isolated for 4 d in their home
cages. On day 1 for habituation, mice were individually placed in a gray
box (30  30  40 cm) for 10 min. Twenty-four hours later, two age-
matched mice in the same genotype that had never encountered each
other before were put into the habituated box and allowed to interact with
each other freely for 10min. Physical interaction, nose-to-nose sniffing, and
following behaviors were measuredmanually in a blindedmanner.
USV test. For pupUSVs, pupswere placed in a glass bowl in a recording
chamber and a recording microphone was placed 20 cm above the pup.
USVs from pups induced by separation from their mothers were re-
corded using Ultrasoundgate (Avisoft, 116Hb) system for 3 min. For
adultUSVs,malemice isolated for 3 d in their home cages and these cages
with mice were placed in a chamber with a microphone 20 cm above the
home cage. Age-matched female mice were introduced to the home cage
for 5 min. Recorded sound files were analyzed using the SASLab Pro
software (Avisoft, RRID:SCR_014438).
Pup retrieval assay. Virgin femalemice at 4months of age were isolated
in their home cages with nesting block for 4 d before the test. Three WT
P1 pups were placed at three different corners away from the nesting
block of the home cage of the test female mouse and the female mouse
was allowed to retrieve the pups for 10min. Latency to each pup retrieval
to the nest was measured.
Repetitive behavior. Self-grooming anddigging tests were performed in
mouse home cages with fresh bedding. Mice were individually placed
into a home cage for 20 min and repetitive behaviors during the last 10
min were used to analyze self-grooming and digging behavior manually.
Marble-burying test. Subjected mice were placed in a home cage with
5-cm-thick beddings and 21 metal marbles and allowed to explore freely
for 30 min. The analysis counted the number of buried marbles in a
blinded manner with marble burying counted when more than the two-
thirds of marbles were buried.
Rotarod test. Rotating speed of rod was gradually increased from 4 to 40
rpm over 5 min. Mice were placed gently on the rotating rod for 20 s, fol-
lowed by the start of rod rotation. The experiment was performed for 5
consecutive days while measuring the latencies of mice to fall from the rod.
Object recognition test. This test was performed in an open-field test
apparatus. Mice were habituated in the apparatus for 1 h/d before train-
ing. For the displaced object recognition test (DORT), after exploring
same 2 objects for 10 min, mice were put back into their home cages for
5 min. One of the two objects was translocated to a position opposite in
the box. Then the mice were placed back in the apparatus and allowed to
explore the objects for 10 min. Exploration time for the translocated
object was measured. For the novel object recognition test (NORT), on
the training day, mice were allowed to explore two same objects for 10
min. Twenty-four hours after training, one of the two objects was re-
placed with a new one and mice were allowed to explore both objects
freely for 10 min. Object exploration was defined by the amount of time
spent for each object, with the nose of the mouse touching or facing
toward the objects within 2 cm from them.
Morris water maze. This assay was performed in a stainless steel round
tank (12 cm diameter) with a hidden platform. The tank was filled with
tap water at temperature of 20–22°C made opaque with white water-
color paint. For memory acquisition, mice were trained to find the plat-
form with 3 trials per day with an intertrial interval of 30 min for 5 d.
When mice reached the platform, they were allowed to rest on the plat-
form for 15 s before being put back into their home cages. If mice did not
find the platform within 60 s, they were guided to the platform and
allowed to rest there for 15 s. On day 6, for probe test, the platform was
removed andmice were put in the center of the tank and allowed to explore
for 1 min. Mice were retrained to find the hidden platform in the tank after
the probe test to avoid memory extinction. On the next day (day 7), the
platform was replaced to a site opposite to the original position and mice
were trained for 4 d for reversal learning and memory. On day 11, another
probe testwas performed to test reversal learning andmemory. Thenumber
of exact crossing over the platform region, quadrant occupancy, and swim-
ming speed were analyzed using EthoVision XT 10 software.
Fear conditioning. On training day,micewere placed in the fear chamber
and allowed to explore the chamber freely for 2 min. Then, the mice went
through 5 rounds of a 20 s tone with a 0.5mA foot shock during the last 2 s,
followedby 40 s of rest. The final shockwas followedby a 2minposttraining
habituation. Twenty-four hours later,micewere returned to the same shock
chamber for 5min to test contextual fear conditioning. Four hours later, the
mice were returned to the chamber with a different context to test cued fear
conditioning. To change the context, mice were placed in a round-shaped
tube added to the chamber and allowed to explore freely for 2min. Then, a 3
min tone was given to test levels of cued fear conditioning.
Acoustic startle and prepulse inhibition. Different mouse cohorts were
used for acoustic startle responses and prepulse inhibition (Wells et al.,
Li, Kim et al. • SALM1/LRFN2 Controls Synapse Development and Behaviors J. Neurosci., June 27, 2018 • 38(26):5872–5887 • 5875
2016). To test acoustic startle responses, the sessionwas preceded by a 5min
exposure to 65 dB background noise. Then each mouse received 92 trials
with intertrial intervals ranging from 7 to 23 s in pseudorandom order. The
trials included apresentationof eight pulse-alone trials (120dB, 40mspulse,
fourweregivenat thebeginningand fourat theendof the test), 77pulse trials
(seven each of 70, 75, 80, 85, 85, 90, 95,100, 105, 110, 115, and 120 dB, 40ms
pulse), and seven trials each without pulse or prepulse inhibition. To test
prepulse inhibition, each mouse received 57 trials with intertrial intervals
ranging from7 to23 spresented inpseudorandomorder.The trials included
a presentation of eight pulse-alone trials (120 dB, 40 ms pulse, four were
given at the beginning and four at the end of the test), 35 prepulse trials
(seven each of 70, 75, 80, 85 and 90 dB, 20ms prepulse given 100ms before
a 120 dB, 40 ms pulse), and seven trials each without pulse or prepulse
presentation. The prepulse inhibition percentage was calculated as follows:
100  (mean prepulse response/mean pulse response)  100). Startle at
each pulse level was averaged across trials.
PTZ-induced seizure. Mice were injected with pentylenetetrazole
(PTZ; 50g/weight in grams) into the intraperitoneal cavity and seizures
recorded for 10 min. Seizures were scored blindly according to Racine
scale designed for PTZ-induced seizures in mice (Ferraro et al., 1999).
Experimental design and statistical analysis. The order of behavioral
tests was designed in a way to minimize stress in animals. The behavioral
experiments were performed in the following order using three indepen-
dent cohorts: (1) cohort 1 underwent elevated plus-maze open-field test
(110 lux), digging and grooming, light/dark test, three-chamber test,
direct interaction test, and PPI and fear conditioning test; (2) cohort 2
underwent open-field test (0 lux), adult USV, acoustic startle response,
and PTZ-induced seizure; and (3) cohort 3 underwent LABORAS test,
displaced object recognition test, novel object recognition test, andMor-
ris watermaze. All statistical tests were performed usingGraphPad Prism
7.0 software (RRID:SCR_002798). Normality of data distribution was
assessed using the D’Agostino–Pearson omnibus test. Comparison of
WT and KO data were performed using unpaired two-tailed Student’s t
test when the data showed Gaussian distribution; Mann–Whitney test or
Wilcoxon test was used when the data followed a non-Gaussian distribu-
tion. Repeated-measures two-way ANOVA was used to determine
between-subject variability (genotype) and within-subject variability
(repeated-measures) for the analysis of the measures of input/output
ratio, paired-pulse facilitation, open field, LABORAS, arotarod, Morris
water maze, fear conditioning, acoustic startle, and prepulse inhibition
tests. Bonferroni’s test followed by ANOVA was used as a post hoc test
for multiple comparisons. All data were displayed as mean 	 SEM.
The age, sex, and numbers of animals and all details of statistical
results are shown in Fig. 1-1 (available at https://doi.org/10.1523/
JNEUROSCI.3321-17.2018.f-1).
Results
Generation and characterization of Lrfn2 /mice
To generate Lrfn2 / mice, we used a mouse embryonic stem
cell line that lacks exon 2 of the Lrfn2 gene encoding most of the
extracellular region of SALM1 (Fig. 1A). This deletion was con-
firmed by PCR genotyping and qRT-PCR (Fig. 1B,C). Immuno-
blot analyses using an anti-SALM1 antibody raised against the
last 30 aa residues of the protein confirmed the lack of SALM1
protein in theLrfn2 /hippocampus (Fig. 1D). Thesemicewere
born in normal Mendelian ratios and did not exhibit any gross
anatomical abnormalities in the brain (Fig. 1E). The Lrfn2 /
brain displayed normal levels of other SALM family proteins
(SALM2-5), glutamate receptor subunits (GluA1/2, GluN1/2A/
2B, and mGluR5), and presynaptic and postsynaptic proteins
(PSD-95, PSD-93,synapsin I, synaptophysin, Homer1, VGluT1,
VGAT, GAD65, and gephyrin), compared with those in WT
mice, as determined by immunoblot analysis of hippocampal
crude synaptosomes (Fig. 1F; t(4) 
 0.7226, p 
 0.5099 for
SALM2; t(4)
 0.2952, p
 0.7826 for SALM3; t(4)
 0.2437, p

0.8194 for SALM4; t(4) 
 1.054, p 
 0.3514 for SALM5; t(6) 

1.747, p
 0.1312 for GluA1; t(6)
 2.281, p
 0.5471 for GluA2;
t(6)
 0.638, p
 0.5471 for GluN1; t(6)
 0.3824, p
 0.7154 for
GluN2A; t(6)
 0.2232, p
 0.8308 for GluN2B; t(6)
 0.6676, p

0.5292 for mGluR5; t(4) 
 0.1, p 
 0.9251 for PSD-95; t(6) 

0.385, p 
 0.7135 for PSD-93; t(6) 
 0.4847, p 
 0.6451 for
synapsin I; t(6) 
 0.5682, p 
 0.5905 for synaptophysin; t(4) 

1.334, p 
 0.2532 for Homer1; t(6) 
 0.2666, p 
 0.7987 for
VGluT1; t(6) 
 0.9887, p 
 0.361 for VGAT; t(6) 
 0.2988, p 

0.7752 for GAD65; t(4) 
 0.1183, p 
 0.9115 for gephyrin, un-
paired t test for all).
Distribution patterns of SALM1mRNA and protein
Wenext determined the distribution pattern of SALM1mRNAat
various developmental stages (E18, P0, P7, P14, P21, and P42) by
in situ hybridization inmouse brain slices. SALM1mRNA signals
in sagittal and horizontal sections, as revealed by two indepen-
dent probes, were relatively strong in cortical areas of the brain
until P0 and gradually increased in other brain regions across
postnatal developmental stages (Fig. 2A).
To determine the distribution pattern of SALM1 protein in the
brain, we used another line of transgenic mice in which the entire
open reading frame of the Lrfn2 gene was replaced with a LacZ cas-
sette (KOMP VG15208; termed Lrfn2-LacZmice; Valenzuela et al.,
2003). X-gal staining of coronal and sagittal sections from Lrfn2-
LacZmice (P46;male heterozygous) revealed that SALM1protein is
highly expressed in various brain regions, including the cortex, hip-
pocampus, amygdala, thalamus, and hypothalamus (Fig. 2B,C).
SALM1 protein was more abundant in layers II/III and VI of the
cortex relative to the middle layers and in CA1 and CA3 regions of
the hippocampus relative to the dentate gyrus. In contrast, SALM1
protein was minimally detected in the striatum and cerebellum.
Suppressed excitatory and inhibitory synaptic transmission
in Lrfn2 /mice
To determine whether Lrfn2 deletion has any effects on synapse
development and function, we first determined spontaneous ex-
citatory and inhibitory synaptic transmission in the CA1 region
of the hippocampus, where SALM1 is highly expressed. We
found that both the frequency and amplitude of mEPSCs in
Lrfn2 / CA1 pyramidal neurons (P21–P23) were comparable
tothosefromWTmice(Fig.3A; t(30)
0.286,p
0.7769for frequency;
t(30)
 0.799, p
 0.4306 for amplitude, unpaired t test).
In contrast, the frequency, but not amplitude, of mIPSCs was
significantly reduced in Lrfn2 / CA1 pyramidal neurons (P20–
P23; Fig. 3B; U 
 54.5, p 
 0.015, Mann–Whitney U test for fre-
quency; t(28)
 0.7699, p
 0.4478, unpaired t test for amplitude).
Similar results were obtained for sEPSCs and sIPSCs, revealing a
specific decrease in sIPSC frequency (Fig. 3C,D; t(31)
 0.4689, p

0.6418, unpaired t test for sEPSC frequency; t(31) 
 1.354, p 

0.1857, unpaired t test for sEPSC amplitude; t(32) 
 2.824,
p
 0.0081, unpaired t test for sIPSC frequency; t(32)
 0.3834, p

0.7039, unpaired t test for sIPSC amplitude); these latter recordings
were obtained in the absence of TTX to allow action potential firing
and network activities. These results suggest that SALM1 deficiency
leads to a decrease in the frequency of inhibitory, but not excitatory,
synaptic transmission in the hippocampal CA1 region and that this
decrease is not compensated by network activities.
To further test whether Lrfn2 deletion leads to similar changes
in other brain regions, we measured mEPSCs and mIPSCs from
layer II/III pyramidal neurons in the prelimbic region of the me-
dial prefrontal cortex (mPFC). We found that the frequency, but
not amplitude, of mEPSCs, was significantly reduced, whereas
mIPSCs were unaltered (Fig. 3E,F; t(29) 
 3.082, p 
 0.0045,
unpaired t test formEPSC frequency;U
 99, p
 0.4232,Mann–
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Whitney U test for mEPSC amplitude; U 
 168, p 
 0.0864,
Mann–Whitney U test for mIPSC frequency; t(42) 
 1.596, p 

0.118, unpaired t test for mIPSC amplitude), a finding that con-
trasts with the results obtained in the hippocampus. These results
collectively suggest that Lrfn2 deletion suppresses the frequency
of excitatory synaptic transmission in the mPFC, but the fre-
quency of inhibitory transmission in the hippocampus.
Decreased inhibitory synapse density in the Lrfn2 /
hippocampus
To further understand themechanismunderlying the suppressed
synaptic transmission in Lrfn2 /mice, we analyzed the density
andmorphology of excitatory and inhibitory synapses using elec-
tron microscopy (EM). Morphologically, excitatory and inhibi-
tory synapses were defined by PSDs apposed to presynaptic axon
terminals and PSDs apposed to GABA immunopositive inhibitory
axon terminals, respectively.We foundno significant changes in the
densityof excitatory synapses in theCA1 stratumradiatumregionof
the Lrfn2 / hippocampus compared with WT controls (Fig.
4A,B; t(4) 
 0.09004, p 
 0.9326 for PSD density; t(4) 
 0.5, p 

0.6433 for PSD length; t(4)
 0, p 0.9999 for PSD thickness; t(4)

0.03165,p
0.9763 forperforated synapse frequency,unpaired t test
forall). Inaddition, therewerenochanges in the length, thickness,or
perforation of Lrfn2 / PSDs.
In contrast, an analysis of inhibitory synapses indicated a sig-
nificant decrease in the density, but not the length or thickness, of
PSDs (Fig. 4C,D; t(4) 
 6.115, p 
 0.0036 for inhibitory PSD
density; t(4)
 1.512, p
 0.2051 for inhibitory PSD length; t(4)

2, p 
 0.1161 for inhibitory thickness, unpaired t test for all).
These results suggest that SALM1 deficiency leads to a decrease in
the density of inhibitory, but not excitatory, synapses in the hip-
pocampus. Together with the synaptic transmission results, these
findings suggest that the reduced inhibitory synapse number con-
tributes to the reduced frequency of inhibitory synaptic transmis-
sion. This conclusion apparently contrasts with the normal levels of
Figure 1. Generation and characterization of Lrfn2 /mice. A, Strategy for the generation of Lrfn2 /mice. B, PCR genotyping of Lrfn2 /mice. HT, Heterozygous; C, Confirmation of
Lrfn2 exon 2 deletion by qRT-PCR analysis of whole-brain mRNAs (P31). D, Lack of LRFN2 protein expression in the Lrfn2 / brain (P21), as determined by immunoblot analysis of hippocampal
lysates: total (Hp) and crude synaptosomal (Hp-P2). Untrans, UntransfectedHEK293 cell lysates; SALM1-Myc, lysates ofHEK293 cells transfectedwith SALM1-Myc.E, Normal grossmorphologyof the
Lrfn2 / brain (P28), as shown by staining for NeuN (a neuronal marker). Scale bar, 1 mm. F, Normal levels of other SALMs (SALM2-5), glutamate receptor subunits [AMPA (GluA1/A2), NMDA
(GluN1/2A/2B), and metabotropic (mGluR5), and synaptic proteins (excitatory and inhibitory presynaptic and postsynaptic), compared with WT levels, as determined by immunoblot analyses of
crude synaptosomal (P2) fractions from the WT and Lrfn2 / hippocampus (P20–P23). Levels of the indicated proteins were normalized to those of-tubulin for genotype comparisons. The
dotted line indicatesWT levels. n
 3mice forWT and 4mice for KO. NS, Student’s t test (for additional details, see Figure 1-1, available at https://doi.org/10.1523/JNEUROSCI.3321-17.2018.f-1).
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inhibitory synaptic proteins such as VGAT and gephyrin in the
Lrfn2 / hippocampus, determined by immunoblot analyses (Fig.
1F).However, this couldbe attributable to the fact that immunoblot
methodsmaybe less sensitive thanelectrophysiologicalorEMmeth-
ods or that synaptic levels of these proteins might have been in-
creased to compensate for the loss of inhibitory synapses.
SALM1 expression in both glutamatergic and
GABAergic neurons
The decrease in inhibitory synapse density associated with
SALM1 deficiency might be attributable to cell-autonomous
changes in CA1 pyramidal neurons and/or alterations in presyn-
aptic GABAergic neurons that express SALM1 protein. To inves-
tigate this, we performed double-FISH experiments for SALM1/
Lrfn2 and the glutamatergic neuron marker Vglut1/2 (vesicular
glutamate transporter-1/2) and the GABAergic neuron marker
Gad1/2 (glutamate decarboxylase-1/2). Signals for SALM1/Lrfn2
mRNA were detected strongly in both hippocampal and cortical
areas, where they were detected in cell bodies positive for
Vglut1/2 as well as Gad1/2 (Fig. 5). These results suggest that
SALM1/Lrfn2 is expressed in both glutamatergic and GABAergic
neurons in the cortex and hippocampus.
Increased NMDAR-mediated synaptic transmission and
suppressed NMDAR-dependent synaptic plasticity in the
Lrfn2 / hippocampus
Although we found that SALM1 deficiency has no effect on ex-
citatory synapse density or spontaneous synaptic transmission in
the hippocampus, given that SALM1 forms a complex with
PSD-95 and NMDARs in vitro and in vivo (Ko et al., 2006;
Morimura et al., 2006; Wang et al., 2006), it is possible that
SALM1 deficiency might alter other aspects of excitatory synapse
development and function. To test this possibility, we first mea-
sured the ratio of evoked NMDAR- and AMPAR-mediated
EPSCs (NMDA/AMPA ratio). Interestingly, these experiments
revealed an increase in the NMDA/AMPA ratio at Lrfn2 /
Figure 2. Distribution patterns of SALM1mRNA and protein.A, In situ hybridization analysis of SALM1/Lrfn2mRNA expression inmouse brain slices at different developmental stages using two
independent probes against two different regions of SALM1/Lrfn2 mRNA. Scale bar, 10 mm. B, C, Distribution pattern of SALM1 protein, as determined by X-gal staining of coronal and sagittal
sections of brain frommale heterozygous (Lrfn2/) mice (P46). Scale bar, 1 mm.
5878 • J. Neurosci., June 27, 2018 • 38(26):5872–5887 Li, Kim et al. • SALM1/LRFN2 Controls Synapse Development and Behaviors
Figure 3. Suppressed excitatory and inhibitory synaptic transmission in Lrfn2 /mice.A, mEPSCsmeasured inWT and Lrfn2 / CA1 pyramidal neurons (P20–P23). n
 17 cells from4WT
mice and 15 cells from 6 KOmice. NS, Student’s t test.B, mIPSCs inWT and Lrfn2 / CA1 pyramidal neurons (P20–P23). n
 15, 3 forWT and 15, 3 for KO. *p 0.05, NS, Mann–Whitney U test
and Student’s t test.C, sEPSCs inWTand Lrfn2 / CA1pyramidal neurons (P20–P23).n
17, 5 forWTand16, 5 for KO.NS, Student’s t test.D, sIPSCs inWTand Lrfn2 / CA1pyramidal neurons
(P20–P23). n
 18, 3 forWT and 16, 3 for KO. **p 0.01, NS, Student’s t test. E, mEPSCs inWT and Lrfn2 /mPFC prelimbic layer II/III pyramidal neurons (P20–P23). n
 15, 3 forWT and 16,
3 for KO. **p 0.01, NS, Mann–Whitney U test and Student’s t test. F, mIPSCs in WT and Lrfn2 /mPFC prelimbic layer II/III pyramidal neurons (P20–P23). n
 17, 3 for WT and 19, 3 for KO.
NS, Mann–Whitney U test and Student’s t test.
Figure4. Decreased inhibitory synapsedensity in the Lrfn2 /hippocampus.A,B, Decreaseddensity of inhibitory, butnot excitatory, synapses in the stratumradiatumregionof theCA1 region
in Lrfn2 / mice (P21), as determined by EM analysis. Excitatory synapses were defined by PSD structures apposed to axon terminals (arrows and double arrowheads for nonperforated and
perforated PSD, respectively) and inhibitory synapses were defined by PSDs apposed to presynaptic axon terminals with immunopositive GABA signals (arrows). Asterisks, GABA immunopositive
axon terminals; d, postsynaptic dendrites; single arrowhead, GABA-immunopositive axon. Scale bar, 500 nm. n
 3 mice for WT and KO. **p 0.01, NS, Student’s t test.
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Schaffer collateral-CA1 pyramidal (SC-CA1) synapses (Fig. 6A;
t(17)
 2.69, p
 0.0155, unpaired t test). In contrast, there were
no genotype differences in basal excitatory synaptic transmission
(input/output relationship) or paired-pulse facilitation, as shown
by field recordings (Fig. 6B,C; for input/output ratio, interac-
tion, F(5,70) 
 0.04395, p 
 0.9988, fiber volley, F(5,70) 
 450.3,
p  0.0001, genotype, F(1,14) 
 0.2457, p 
 0.6353, repeated-
measures two-way ANOVA; for paired-pulse ratio, interaction,
F(5,35)
 0.07325, p
 0.9959, interval, F(5,35)
 39.53, p 0.0001,
genotype, F(1,7) 
 0.1602, p 
 0.7009, repeated-measures two-
way ANOVA), suggesting that AMPAR-mediated excitatory syn-
aptic transmission and the probability of presynaptic glutamate
release are normal at Lrfn2 / SC-CA1 synapses. However,
there was a significant increase in the NMDAR component of ex-
citatory synaptic transmission, as shown by NMDAR-mediated
EPSCs (Fig. 6D; interaction, F(7,224)
 1.341, p
 0.2320, stimu-
lus, F(7,224) 
 189.9, p  0.0001, genotype, F(1,32) 
 5.106, p 

0.0308, repeated-measures two-way ANOVA; for each stimulus
point, 0.5, p
 0.0635; 1.0, p
 0.0331; 1.5, p
 0.0210; 2.0, p

0.0251; 2.5, p
 0.0163; 3.0, p
 0.0591; 3.5, p
 0.0766; 4.0, p

0.0644, one-way ANOVA). These results suggest that the dele-
tion of Lrfn2 in mice leads to an increase in NMDAR-
mediated, but not AMPAR-mediated, excitatory synaptic
transmission.
Given that NMDAR function regulates synaptic plasticity, af-
fecting both LTP and LTD, we measured these parameters at
Lrfn2 / SC-CA1 synapses. Contrary to our initial expectation
that NMDAR-dependent synaptic plasticity would be increased,
we found that LTP induced by TBS (TBS-LTP) at Lrfn2 / syn-
apses was normal (Fig. 6E; t(21) 
 0.866, p 
 0.3963, unpaired t
test). In contrast, LTP induced by HFS (HFS-LTP) and LTD
induced by LFS (LFS-LTD) were significantly decreased at
Lrfn2 / synapses (Fig. 6F,G; for HFS-LTP, t(29) 
 2.128, p 

0.042, unpaired t test; for LFS-LTD, t(22) 
 2.239, p 
 0.0356,
unpaired t test). These results collectively suggest that SALM1
deficiency suppresses specific forms of NMDAR-dependent LTP
and LTD without affection basal excitatory transmission or pre-
synaptic neurotransmitter release.
Normal locomotion and anxiety-like behavior in Lrfn2 /
mice
To determine the impacts of SALM1 deletion on behaviors, we
subjected Lrfn2 / mice to a battery of behavioral tests.
Lrfn2 / mice showed normal locomotor activity in the open-
field test under both bright-light (110 lux) and light-off (0 lux)
conditions (Fig. 7A,B; 110 lux, interaction, F(5,125)
 1.007, p

0.4162, time, F(5,125) 
 72.97, p  0.0001, genotype, F(1,25) 

0.2067, p
 0.6533, repeated-measures two-way ANOVA for dis-
tance moved; 0 lux, interaction, F(5,135) 
 0.3176, p 
 0.9017,
time, F(5,135) 
 67.05, p  0.0001, genotype, F(1,27) 
 0.02887,
p 
 0.8663, repeated-measures two-way ANOVA for distance
moved). Continuousmonitoring of mousemovements for 3 d in
a home cage-like environment (LABORAS cage) revealed no ab-
normalities in the locomotor activity of Lrfn2 /mice (Fig. 7C;
interaction, F(35,945) 
 1.02, p 
 0.4376, time, F(35,945) 
 61.15,
p  0.0001, genotype, F(1,27) 
 0.3567, p 
 0.5553, repeated-
measures two-way ANOVA).
Lrfn2 / mice showed normal anxiety-like behaviors in the
elevated plus-maze (Fig. 7D; t(29)
 0.3131, p
 0.7564 for time
spent in closed arms; t(29)
 1.304, p
 0.2026 for time spent in
open arms, unpaired t test for all), the light/dark test (Fig. 7E; t(29)

0.7436, p
 0.4631, unpaired t test), and the open-field test (cen-
ter time; Fig. 7A,B; 100 lux, t(25) 
 0.8096, p 
 0.4258; 0 lux,
t(27) 
 0.5809, p 
 0.5661, unpaired t test for all). These results
collectively suggest that SALM1deficiency hasminimal effects on
locomotor activity and anxiety-like behavior.
Suppressed USVs in Lrfn2 / pups, but normal social
interaction and repetitive behaviors, in adult Lrfn2 /mice
We next examined social behaviors. Lrfn2 / mice displayed
normal social interaction and social novelty recognition in the
three-chamber test (Fig. 8A; O1 vs S1, chamber time, t(13) 

Figure 5. Lrfn2 mRNA is detected in both glutamatergic and GABAergic neurons. Expression of SALM1/Lrfn2 mRNA in glutamatergic and GABAergic neurons was determined by FISH. Coronal
sections frommouse brains (male, 8weeks)were triply stained for SALM1/Lrfn2 andVglut1/2 (glutamatergic neuronmarkers) andGad1/2 (GABAergic neuronmarkers) and counterstainedwith the
nuclear dyeDAPI. Amixture of twoprobes (Vglut1Vglut2 or Gad1Gad2)was used to label all glutamatergic or GABAergic neurons. The indicated cortical andhippocampal regions in the image
at left were enlarged on the right to highlight the expression of Lrfn2mRNA in both glutamatergic and GABAergic neurons; Lrfn2 expression in GABAergic neurons is further highlighted by arrows.
Scale bar, 50m.
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8.066, p  0.0001, paired t test for WT; W 
 143, p 
 0.0002,
Wilcoxon matched-pairs signed-rank test for KO; sniffing time,
t(13)
 11.36, p 0.0001, paired t test for WT, t(16)
 9.846, p
0.0001, paired t test for KO; S1 vs S2, chamber time, t(13)
 2.287,
p
 0.0396, paired t test forWT, t(15)
 2.314, p
 0.0325, paired
t test for KO; sniffing time, t(13)
 3.898, p
 0.0018, paired t test
for WT, W
 143, p
 0.0002, Wilcoxon matched-pairs signed-
rank test for KO), and the direct social interaction test (Fig. 8B;
nose-to-nose, t(13)
 0.2337, p
 0.8188; following, t(13)
 0.1277,
p
 0.9004; total, t(13)
 1.633, p
 0.12165, unpaired t test for all).
MeasurementsofUSVsrevealed that femaleencounters elicitednor-
mal levels of USVs in adult male Lrfn2 /mice (Fig. 8C; call num-
ber, t(27) 
 0.8255, p 
 0.4163; call duration, t(27) 
 0.4588, p 

0.6501, unpaired t test for all). In addition, adult female Lrfn2 /
mice retrieved pups to an extent similar to that ofWT females (Fig.
8D; pup1,U
 240, p
 0.9768; pup2,U
 226.5, p
 0.7315; pup3,
U 
 213, p 
 0.5106, Mann–Whitney U test for all). In contrast,
USVs emitted byLrfn2 / pups separated from theirmotherswere
diminished, as shown by the number of calls and individual call
duration (Fig. 8E; call number, P4, t(36) 
 0.4562, p 
 0.651, un-
paired t test; P6, U
 90.5, p
 0.0088, Mann–Whitney U test; P8,
t(30)
 1.123, p
 0.2702, unpaired t test; P10,U
 79, p
 0.0216,
Mann–Whitney U test; call duration, P4, U 
 175, p 
 0.9884,
Mann–WhitneyU test; P6, t(36)
 1.448, p
 0.1564, unpaired t test;
P8, t(30)
 1.878, p
 0.0702, unpaired t test; P10, t(33)
 1.492, p

0.1452, unpaired t test).
In tests measuring repetitive behaviors, Lrfn2 / mice
showed normal levels of self-grooming, digging, and marble
burying in home cages (Fig. 8F,G; digging, U
 95, p
 0.3561,
Mann–WhitneyU test; self-grooming, t(29)
 0.5169, p
 0.6092,
unpaired t test; marble burying, t(27) 
 0.5795, p 
 0.5671, un-
paired t test). In addition, Lrfn2 /mice showed normal motor
coordination and learning in the rotarod test (Fig. 8H; interac-
tion, F(4,116) 
 0.1178, p 
 0.9760; time, F(4,116) 
 23.56, p 
0.0001; genotype, F(1,29) 
 0.1653, p 
 0.6873, repeated-
measures two-way ANOVA). Collectively, these results suggest
that SALM1 deficiency does not affect social interaction or repet-
itive behaviors, but does affect USVs, a form of social communi-
cation, in pups but not in adult mice.
Figure 6. Increased NMDAR-mediated synaptic transmission and suppressed NMDAR-dependent synaptic plasticity in the Lrfn2 / hippocampus. A, Increased ratio of NMDAR/AMPAR-
mediated synaptic transmission at Lrfn2 / SC-CA1 synapses (P21–P24),measured as AMPA andNMDA EPSCs evoked at holding potentials of70 and40mV, respectively. n
 9 slices from
8 mice for WT and 10 slices from 8 mice for KO. *p 0.05, Student’s t test. B, Normal basal transmission at Lrfn2 / SC-CA1 synapses (P30–P35), as shown by the input/output relationship
between fiber volley and fEPSP slopes. n
 8, 3 forWT and KO, repeated-measures two-way ANOVA. C, Normal paired-pulse facilitation at Lrfn2 / SC-CA1 synapses (P30–P35), as shownby the
relationship between interpulse intervals and fEPSP slopes. n
 8, 3 forWT and KO, repeated-measures two-way ANOVA.D, Increased NMDAR EPSCs at Lrfn2 / SC-CA1 synapses (P22–P27), as
shown by the relationship between stimulus intensities and initial slopes of NMDAR EPSCs. N
 18, 5 forWT and 16, 4 for KO. *p 0.05, repeated-measures two-way ANOVA and one-way ANOVA.
E, Normal TBS-LTP at Lrfn2 / SC-CA1 synapses (P28–P36). Bar graphs represent average values during the last 10 min. n
 13, 5 for WT and 10, 6 for KO. NS, Student’s t test. F, Suppressed
HFS-LTP at Lrfn2 / SC-CA1 synapses (P28–P36). Bar graphs represent average values during the last 10min.n
15, 7 forWTand16, 7 for KO. *p0.05, Student’s t test.G, Suppressed LFS-LTD
at Lrfn2 / SC-CA1 synapses (P16–P20). Bar graphs represent average values during the last 10 min. n
 13, 5 for WT and 11, 6 for KO. *p 0.05, Student’s t test.
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Normal learning andmemory in Lrfn2 /mice
Turning to learning and memory behaviors, we found that
Lrfn2 /mice performed normally in the novel object recogni-
tion test and displaced object recognition tests (Fig. 9A,B; for
novel object test, t(33) 
 1.436, p 
 0.1603, unpaired t test; for
displaced object recognition test, t(30)
 0.7224, p
 0.4756, un-
paired t test). In the Morris water maze test, Lrfn2 / mice
showed normal levels of learning andmemory in learning, probe,
and reversal phases (Fig. 9C–H; for escape latency, interaction,
F(8,136)
 0.6172, p
 0.7623, time, F(8,136)
 45.03, p 0.0001,
genotype, F(1,17)
 0.02015, p
 0.8888, repeated-measures two-
way ANOVA; for quadrant occupancy, t(17)
 1.287, p
 0.2155,
unpaired t test for target; t(17)
 1.732, p
 0.1014, unpaired t test
for left; t(17)
 0.248, p
 0.8071, unpaired t test for right; t(17)

0.148, p
 0.8841, unpaired t test for opposite; for crossing num-
ber, U 
 34, p 
 0.3796, Mann–Whitney U test; for velocity,
t(17)
 0.1917, p
 0.8503, unpaired t test; for reversal quadrant
occupancy, t(17) 
 2.665, p 
 0.0163, unpaired t test for target;
t(17) 
 1.393, p 
 0.1815, unpaired t test for pre_target; t(17) 

1.432, p 
 0.1702, unpaired t test for left; t(17) 
 0.8738, p 

0.3944, unpaired t test for right; for reversal crossing number,
t(17)
 0.3929, p
 0.6993, unpaired t test). In fear conditioning
tests, in which mice were exposed to foot shocks in a spatial
context combined with a tone, Lrfn2 / mice showed normal
levels of freezing in the same spatial context 24 h after acquisition
of fear memory (Fig. 9 I, J; interaction, F(4,116) 
 0.2241, p 

0.9245, time, F(4,116) 
 37.34, p  0.0001, genotype, F(1,39) 

0.00663, p 
 0.9357, repeated-measures two-way ANOVA; for
pre-training,U
 98.5, p
 0.3437,Mann–WhitneyU test; t(29)

1.163, p
 0.2545, unpaired t test). Freezing induced by the same
sound cues (Cs) 28 h after fearmemory acquisitionwas also normal
in Lrfn2 /mice (Fig. 9K; t(29)
 1.595, p
 0.1215, unpaired t test
forpre-Cs24h; t(29)
1.596,p
0.1212,unpaired t test forCs24h).
These results collectively suggest that SALM1 deficiency hasminimal
effects on learning andmemory behaviors.
Enhanced acoustic startle, but normal prepulse inhibition
and susceptibility to induced seizure, in Lrfn2 /mice
Finally, to assess behaviors in sensory and motor domains, we
first measured acoustic startle responses. Lrfn2 /mice showed
enhanced startle responses to stimuli in a high loudness range
(110 dB; Fig. 10A; interaction, F(12,504) 
 2.926, p 
 0.0006,
time, F(12,504) 
 133, p  0.0001, genotype, F(1,42) 
 3.192, p 

0.0812; 0 dB, p 0.9999; 65, p 0.9999; 70, p 0.9999; 75, p
0.9999; 80, p  0.9999; 85, p  0.9999; 90, p  0.9999; 95, p 
0.9999; 100, p  0.9999; 105, p  0.9999; 110, p  0.9999; 115,
p  0.9999; 120, p  0.9999, repeated-measures two-way
ANOVA, Bonferroni’s multiple comparison test). In contrast,
prepulse inhibition was normal in Lrfn2 /mice, despite a ten-
dency toward a decrease (Fig. 10B; interaction, F(4,116)
 0.4163,
p
 0.7966, time, F(4,116)
 130, p 0.0001, genotype, F(1,29)

2.908, p 
 0.0988, repeated-measures two-way ANOVA), sug-
gesting that sensory motor integration is normal.
In a test measuring seizure susceptibility, Lrfn2 / mice
showed normal susceptibility to seizures induced by PTZ com-
pared with WT mice (Fig. 10C; p 
 0.7513, 2 analysis). These
results collectively suggest that SALM1deficiency leads to sensory
hypersensitivity, but has a minimal impact on sensory motor
integration or seizure susceptibility.
Figure 7. Normal locomotion and anxiety-like behavior in Lrfn2 /mice. A, B, Normal locomotor activity and anxiety-like behavior of Lrfn2 /mice (3 months) in open-field tests at two
different light intensities (110 and 0 lux), as shown by distance moved and time spent in the center region of the open-field arena. n
 13mice for WT and 14mice for KO (110 lux), and 13 for WT
and 16 for KO (0 lux). NS, repeated-measures two-way ANOVA and Student’s t test. C, Normal locomotor activity of Lrfn2 /mice (2 months) in LABORAS cages, where mouse movements were
monitored for 3 consecutive days. n
 13 forWT and 16 for KO. NS, repeated-measures two-way ANOVA.D, Normal anxiety-like behavior of Lrfn2 /mice (4months) in the elevated plus-maze
test. n
 14 for WT and 17 for KO. NS, Student’s t test. E, Normal anxiety-like behavior of Lrfn2 /mice (4 months) in the light/dark test. n
 14 for WT and 16 for KO. NS, Student’s t test.
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Discussion
SALM1 deficiency alters NMDAR-dependent
synaptic plasticity
SALM1 has been shown to form a complex with NMDARs in
vitro and in vivo and to regulate dendritic surface clustering of
NMDARs in cultured hippocampal neurons (Wang et al., 2006).
We thus expected that SALM1 deficiency in mice would lead to a
reduction in NMDAR function. However, our results indicated
that SALM1 deficiency causes an increase inNMDAR function in
the hippocampus, as evidenced by an increase in NMDA/AMPA
ratio and NMDA-EPSCs with normal AMPAR-mediated basal
synaptic transmission.
This unexpected increase in NMDAR function led us to
predict enhanced NMDAR-dependent synaptic plasticity in
Lrfn2 /mice. However, we found that, although TBS-LTP was
normal, NMDAR-dependent HFS-LTP and LFS-LTD were sig-
nificantly reduced. What might explain these results? One possi-
bility is that abnormally enhanced NMDAR-mediated synaptic
transmission at Lrfn2 / excitatory synapses caused secondary
changes in the molecular pathways downstream of NMDAR
activation, suppressing NMDAR activation-dependent recruit-
ment or removal of AMPARs during synaptic plasticity. Alterna-
tively, the increase in NMDAR function may merely represent a
compensatory change induced by defective synaptic plasticity.
These possibilities, which are not mutually exclusive, would cre-
ate a situation in which NMDAR-mediated synaptic transmis-
sion is enhanced and NMDAR-dependent synaptic plasticity is
suppressed. Given that SALM1 associates with NMDARs in vivo
and promotes dendritic clustering of NMDARs in cultured neu-
rons (Wang et al., 2006), it is unlikely that SALM1deletionwould
markedly increase NMDAR-mediated synaptic transmission,
making the latter possibility more likely. Although further details
remain to be determined, our in vivo results clearly point to the
possibility that SALM1 is required for bidirectional activity-
dependent changes in AMPAR-mediated synaptic transmission
during NMDAR-dependent synaptic plasticity.
In contrast to these significant changes in NMDAR-de-
pendent synaptic plasticity, multiple lines of evidence suggest
that SALM1 deficiency has little effect on the development of
excitatory synapses, at least in the hippocampus. First, the density
of excitatory synapseswas normal in the Lrfn2 /hippocampus,
as supported by the normal density of excitatory synapses in EM
analyses and the normal frequencies of mEPSCs and sEPSCs. In
addition, the size and shape of excitatory synapses were mini-
Figure 8. Suppressed USVs in pups, but normal social interaction, communication, and repetitive behaviors in adult Lrfn2 /mice.A, Normal social approach and social novelty recognition in
Lrfn2 /mice (3–4months) in the 3-chamber test, as shown by time spent in the chamber and sniffing. n
 14mice for WT and 17mice for KO. *p 0.05, **p 0.01, ***p 0.001, paired
t test andWilcoxon test.B, Normal social interaction in Lrfn2 /mice (3–4months) in the direct social interaction test.n
 7WTmouse pairs and 8KOmouse pairs. NS, Student’s t test. C, Normal
USVs of male Lrfn2 /mice (4–5 months) induced by encounter with a female. n
 13 mice for WT and 16 mice for KO. NS, Student’s t test. D, Normal pup retrieval in female Lrfn2 /mice
(3–5months) inducedbyWTpups (P1) separated from theirmothers, as shownby the time taken to retrieve first, second, and third pups.n
23mice forWTand21mice for KO.NS,Mann–Whitney
U test. E, Suppressed USVs in Lrfn2 / pups (P4, P6, P8, and P10) separated from their mothers, as shown by number of calls and individual call duration. For P4, n
 16mice forWT and 22mice
for KO; for P6, n
 17 forWT and 21 for KO; for P8, n
 11 forWT and 21 for KO; for P10, n
 14 forWT and 21 for KO. *p 0.05, **p 0.01, NS, Student’s t test andMann–Whitney U test. F, G,
Normal repetitive behaviors of Lrfn2 /mice (3–4 months), as shown by self-grooming, digging, and marble burying. For digging and grooming, n
 14 mice for WT and 17 mice for KO; for
marble burying, n
 13 for WT and 16 for KO. NS, Student’s t test and Mann–Whitney U test.H, Normal motor coordination of Lrfn2 /mice (4–5months) in the rotarod test. n
 14mice for
WT and 17 mice for KO. NS, repeated-measures two-way ANOVA.
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mally affected, as supported by the normal length, thickness, and
perforation of PSDs in EManalyses and the normal amplitudes of
mEPSCs and sEPSCs. Therefore, an Lrfn2 deficiency appears to
have a greater effect on excitatory synaptic plasticity than on
excitatory synapse development.
The findings reported here regarding excitatory synapses
differ somewhat from those observed in the hippocampus of
another Lrfn2 / mouse line (Morimura et al., 2017). The in-
vestigators in that study reported major abnormalities in
themorphology of excitatory synapses and dendritic spines in the
hippocampus, with longer and thinner spines andmore frequent
oddly shaped spinule-like structures (Morimura et al., 2017).
Our data, however, indicate no changes in the morphology of
excitatory synapses, again, as supported by the normal length,
thickness, and perforation of the PSD, results that are consistent
with the normal amplitude of mEPSCs.
In terms of NMDAR function, this latter study found in-
creases in the NMDA/AMPA ratio similar to those found here,
but reported that LTP, an NMDAR-dependent function, was
changed in the opposite direction: whereas our study found
suppressed HFS-LTP, this previous study reported enhanced
HFS-LTP. This reported increase in LTP could be attributable
to the increased number of silent synapses observed in their
mice because silent synapses would have more room to ac-
commodate incoming AMPARs during LTP. Our Lrfn2 /
mice, however, appeared to have normal silent synapses, as
supported by the normal frequency of mEPSCs. Therefore,
silent synapses could not explain our LTP phenotype; more-
over, LTP was suppressed rather than enhanced in our mice.
However, it should be noted that NMDAR and LTP pheno-
types in the two mouse lines arguably involve a similar defect,
limited NMDAR-dependent synaptic delivery of AMPARs, al-
though these defects appear to occur at different stages of
synapse development: an early unsilencing stage of excitatory
synapses and a relatively late post-unsilencing stage of excit-
atory synapse maturation.
Figure 9. Normal learning andmemory in Lrfn2 /mice.A, Normal novel object recognitionmemory in Lrfn2 /mice (2–3months). n
 17mice forWT and 18mice for KO. NS, Student’s
t test.B, Normal displacedobject recognitionmemory in Lrfn2 /mice (2–3months).n
16mice forWTandKO.NS, Student’s t test.C–H, Normal learningandmemory in Lrfn2 /mice (3–4
months) in the learning, probe, and reversal phases of theMorriswatermaze test. Pre-T, Previous target.n
 9mice forWT and10mice for KO. *p 0.05, NS, repeated-measures two-wayANOVA,
Student’s t test, andMann–Whitney U test. I–K, Normal fear learning andmemory in Lrfn2 /mice (4–5months). Mice with acquired fear memory in a spatial context combined with a sound
cue (I ) were tested for contextual fear memory 24 h after training (J ) and for cued fear memory 28 h after training (K ). n
 14 mice for WT and 17 mice for KO. NS, repeated-measures two-way
ANOVA, Student’s t test, and Mann–Whitney U test.
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Both studies used mice that lacked the same exon 2 of the
Lrfn2 gene and had the same genetic background (C57BL/6J). Pos-
sible explanations for discrepancies in synapse phenotypes could
include differences in conditions in whichmice were bred and han-
dled, theagesofmiceused for slice recordings (P21–P35 inour study
and 3–6months in the prior study), themethod for preparing brain
slices, or electrophysiology conditions (e.g., buffer solutions).
SALM1 deficiency suppresses inhibitory
synapse development
An unexpected finding of our study was that an Lrfn2 deficiency
leads to suppression of inhibitory synapse development in the
hippocampus, as supported by the decreased density of inhibi-
tory synapses in EM analyses and the decreased frequency of
mIPSCs and sIPSCs (Figs. 3, 4). It is possible that SALM1 could be
targeted to inhibitory postsynaptic sites in CA1 pyramidal neu-
rons, in addition to excitatory synapses, where it may regulate
inhibitory synapse development, perhaps by participating in
trans-synaptic adhesion with as yet unknown presynaptic li-
gands. Although SALM1 is known to associate with excitatory
postsynaptic proteins such as PSD-95 and NMDARs (Ko et al.,
2006; Morimura et al., 2006; Wang et al., 2006), SALM1 might
also be targeted to inhibitory postsynaptic sites through cis inter-
actions with other SALMs such as SALM4 and SALM5 (Wang et
al., 2008; Lie et al., 2016, 2018), which do not have PSD-95-
binding C-terminal tails and might be localized to inhibitory
synapses. In addition, these cis interactionsmight bemediated by
the dimerization of SALMs recently identified in SALM5 and
SALM2 by x-ray crystallographic studies (Goto-Ito et al., 2018;
Lin et al., 2018). However, proteomic studies using proximity
biotinylation have identified SALM1 at excitatory but not inhib-
itory synapses (Loh et al., 2016; Uezu et al., 2016), although these
results do not preclude the possibility that SALM1 localizes at
inhibitory synaptic sites.
Alternatively, SALM1 may be expressed in presynaptic
GABAergic neurons. Indeed, our FISH experiments revealed the
presence of SALM1/Lrfn2 mRNA signals in cortical and hip-
pocampal GABAergic neurons in addition to glutamatergic neu-
Figure 10. Enhanced acoustic startle, but normal prepulse inhibition and susceptibility to induced seizure, in Lrfn2 /mice. A, Enhanced acoustic startle responses of Lrfn2 /mice (4–5
months) in a high loudness range (110 dB). n
 20 mice for WT and 24 mice for KO. **p 0.01, ***p 0.001, repeated-measures two-way ANOVA with Bonferroni test. B, Normal prepulse
inhibition in Lrfn2 /mice (4–5months). n
 14mice for WT and 17mice for KO. Repeated-measures two-way ANOVA. C, Normal susceptibility to a seizure induced by PTZ (40 mg/kg, i.p.) in
Lrfn2 /mice (5–6months). The numbers in pie charts indicate the proportions of mice that reached the indicated stages of seizure at the end of the test (10 min). n
 13 mice for WT and 16
mice for KO. NS, 2 analysis.
Li, Kim et al. • SALM1/LRFN2 Controls Synapse Development and Behaviors J. Neurosci., June 27, 2018 • 38(26):5872–5887 • 5885
rons. In GABAergic neurons, SALM1 may be targeted to
presynaptic axon terminals, where it could participate in trans-
synaptic adhesion or regulate presynaptic differentiation. Con-
sistent with this possibility, SALM1 immunogold EM signals
have been detected in presynaptic nerve terminals (Thevenon et
al., 2016). Another possibility is that SALM1 in GABAergic neu-
rons may be targeted to dendritic excitatory synapses. A lack of
SALM1 at these sites might suppress excitatory synapse develop-
ment or function, consequently suppressing the output functions
of GABAergic neurons.
SALM1 deficiency alters social communication and
startle behavior
In our study, we found that Lrfn2 KO led to suppression of USVs
in pups and enhancement of acoustic startle responses in adults.
Our Lrfn2 / mice, however, were largely normal in other be-
havioral domains, including locomotion, anxiety-like behavior,
social interaction, repetitive behavior, learning andmemory, and
seizure propensity. Behavioral test results reported for the previ-
ous Lrfn2 / mouse line (Morimura et al., 2017) show some
overlap with ours, but are largely dissimilar. The most similar
reported behavior is enhanced acoustic startle; the concurrence
of the two studies on this point strongly suggests that SALM1 is
required for normal development of auditory startle responses.
The prior study did not observe any changes in pup USVs, an-
other strong phenotype observed in our mice. Behaviors that
were uniquely observed in the previously reported Lrfn2 /
mouse line include suppressed social interaction, enhanced
repetitive behavior, and enhanced learning and memory (Mo-
rimura et al., 2017). Again, these discrepancies could be attribut-
able to differences in experimental conditions, including mouse
breeding and handling. Importantly, the time at which behav-
ioral experiments were performed differed between the two stud-
ies: during a lights-off period for our study and during a lights-on
period for the prior study.
The acoustic startle response has been shown to involve oli-
gosynaptic circuits and a small group of giant neurons in the
caudal nucleus of the pontine reticular formation (PnC) (Yeo-
mans and Frankland, 1995; Koch and Schnitzler, 1997), a brain
region where SALM1/Lrfn2 mRNA signals are detectable, albeit
at relatively low levels; moreover, current images lack sufficient
cellular resolution to provide reliable information on this point
(Fig. 3 and Allen Brain Atlas). In addition, inhibition of
NMDARs in the PnC by local infusion of AP5 has been shown to
suppress the acoustic startle response markedly in rats (Miseren-
dino andDavis, 1993). Given the abnormally enhanced NMDAR
function in the Lrfn2 / hippocampus, it is tempting to specu-
late that SALM1 deletion in the PnC might lead to abnormal
increases in NMDAR function and acoustic startle response.
USVs are an important mode of social communication in
rodents and deficits in USVs have been observed in many mouse
models of ASD (Scattoni et al., 2009; Wo¨hr, 2014). Intriguingly,
our Lrfn2 / mice showed suppressed isolation-induced USVs
in pups, but normal female-induced USVs in adults. This differ-
ence may be attributable to the distinct nature of the two USV
types: pup USVs are more anxiety- and development-related be-
haviors, whereas adult USVs are more reproduction related
(Scattoni et al., 2009). Indeed, distinct pup and adult USV phe-
notypes have been reported in neuroligin-2-KOmice, which also
show suppressed pup USVs but normal adult USVs (Wo¨hr et al.,
2013).
Pup USVs are known to involve many brain regions, includ-
ing the periaqueductal gray (PAG) and amygdala (Hofer, 1996),
where SALM1/Lrfn2 mRNA is expressed (Fig. 2 and Allen Brain
Atlas). In addition, NMDAR inhibition has been shown to sup-
press isolation-induced pup USVs in rats and mice (Winslow et
al., 1990). Mouse pups also respond similarly, although certain
NMDAR antagonists seem to induce biphasic responses; en-
hanced and suppressed USVs at low and high concentrations,
respectively (Takahashi et al., 2009). Therefore, SALM1 deletion
in mice might abnormally enhance pup USVs through NMDAR
hyperactivity in brain regions that include the PAG and
amygdala. In addition, because SALM1/LRFN2 has been impli-
cated in ASD (Morimura et al., 2017), the reduction in pupUSVs
in Lrfn2 / mice may represent a novel autistic-like behavior.
This is a potentially valuable tool because early symptoms are
relatively common in human ASDs, but early behavioral mea-
sures are rare in animal models of ASD (Silverman et al., 2010;
Wo¨hr and Scattoni, 2013).
In conclusion, our results suggest that SALM1 is important for
NMDAR function at excitatory synapses and is required for nor-
mal synapse development at inhibitory synapses. Behaviorally,
SALM1 is required for normal pupUSVs and acoustic startle, but
not for the other behaviors tested.
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